Cargando…
Mycoplasmas and cancer: focus on nucleoside metabolism
The standard of care for patients suffering cancer often includes treatment with nucleoside analogues (NAs). NAs are internalized by cell-specific nucleobase/nucleoside transporters and, after enzymatic activation (often one or more phosphorylation steps), interfere with cellular nucleo(s)(t)ide met...
Autores principales: | Vande Voorde, Johan, Balzarini, Jan, Liekens, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464442/ https://www.ncbi.nlm.nih.gov/pubmed/26417262 |
Ejemplares similares
-
Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs
por: Vande Voorde, Johan, et al.
Publicado: (2015) -
Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides
por: Hulpia, Fabian, et al.
Publicado: (2018) -
Synthesis and Evaluation
of Prodrugs of α-Carboxy
Nucleoside Phosphonates
por: Ford, Alan, et al.
Publicado: (2022) -
2-Amino-3-methylcarboxy-5-heptyl-thiophene (TJ191) is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells
por: El-Gazzar, Ahmed, et al.
Publicado: (2017) -
Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication
por: Barral, Karine, et al.
Publicado: (2011)